Phibro Animal Health (PAHC) Amortization of Deferred Charges (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Amortization of Deferred Charges of $572000.0 in Q1 2026, little changed quarter-over-quarter from $572000.0 in Q4 2025, and little changed on a YoY basis from $572000.0 in Q1 2025.
Phibro Animal Health (PAHC) Amortization of Deferred Charges (2013 - 2026) Analysis & Trends
Phibro Animal Health's Amortization of Deferred Charges history runs 14 years deep, the most recent figure standing at $572000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $572000.0; the TTM figure through Mar 2026 stood at $2.3 million (up 34.35% YoY), while the FY2025 annual figure was $2.0 million, up 93.75% from the prior year.
- Amortization of Deferred Charges was $572000.0 for Q1 2026 at Phibro Animal Health, roughly flat from $572000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $572000.0 in Q1 2025 to a low of $147000.0 in Q1 2022.
- Historically, Amortization of Deferred Charges has averaged $340764.7 across 5 years, with a median of $260000.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges slumped 33.48% in 2022, then soared 120.0% in 2025.
- A 5-year view of Amortization of Deferred Charges shows it stood at $179000.0 in 2022, then soared by 45.25% to $260000.0 in 2023, then surged by 93.85% to $504000.0 in 2024, then climbed by 13.49% to $572000.0 in 2025, then changed by 0.0% to $572000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $572000.0 (Q1 2026), $572000.0 (Q4 2025), and $572000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 572,000.00 |
| Mar 31, 2026 | 572,000.00 |
| Dec 31, 2025 | 572,000.00 |
| Dec 31, 2025 | 572,000.00 |
| Sep 30, 2025 | 572,000.00 |
| Sep 30, 2025 | 572,000.00 |
| Jun 30, 2025 | 572,000.00 |
| Jun 30, 2025 | 572,000.00 |
| Mar 31, 2025 | 572,000.00 |
| Mar 31, 2025 | 572,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | 260,000.00 |
| Jun 30, 2024 | 260,000.00 |
| Mar 31, 2024 | 260,000.00 |
| Mar 31, 2024 | 260,000.00 |
| Dec 31, 2023 | 260,000.00 |
| Dec 31, 2023 | 260,000.00 |